Replies to post #160700 on Biotech Values

[jq1234]

I do, I think it will be a full and thorough review, not a simple reformulation sNDA. Otherwise, it wouldn't have taken this long to file. It could be like Myozyme sBLA that turned into a new Lumizyme BLA after FDA reviewed the filing.